Literature DB >> 11156533

Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease.

Y Pei1, A D Paterson, K R Wang, N He, D Hefferton, T Watnick, G G Germino, P Parfrey, S Somlo, P St George-Hyslop.   

Abstract

In searching for a putative third gene for autosomal dominant polycystic kidney disease (ADPKD), we studied the genetic inheritance of a large family (NFL10) previously excluded from linkage to both the PKD1 locus and the PKD2 locus. We screened 48 members of the NFL10 pedigree, by ultrasonography, and genotyped them, with informative markers, at both the PKD1 locus and the PKD2 locus. Twenty-eight of 48 individuals assessed were affected with ADPKD. Inspection of the haplotypes of these individuals suggested the possibility of bilineal disease from independently segregating PKD1 and PKD2 mutations. Using single-stranded conformational analysis, we screened for and found a PKD2 mutation (i.e., 2152delA; L736X) in 12 affected pedigree members. Additionally, when the disease status of these individuals was coded as "unknown" in linkage analysis, we also found, with markers at the PKD1 locus, significant LOD scores (i.e., >3.0). These findings strongly support the presence of a PKD1 mutation in 15 other affected pedigree members, who lack the PKD2 mutation. Two additional affected individuals had trans-heterozygous mutations involving both genes, and they had renal disease that was more severe than that in affected individuals who had either mutation alone. This is the first documentation of bilineal disease in ADPKD. In humans, trans-heterozygous mutations involving both PKD1 and PKD2 are not necessarily embryonically lethal. However, the disease associated with the presence of both mutations appears to be more severe than the disease associated with either mutation alone. The presence of bilineal disease as a confounder needs to be considered seriously in the search for the elusive PKD3 locus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156533      PMCID: PMC1235269          DOI: 10.1086/318188

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  PKD3-to be or not to be?

Authors:  A D Paterson; Y Pei
Journal:  Nephrol Dial Transplant       Date:  1999-12       Impact factor: 5.992

2.  Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.

Authors:  M Floeth; L Bruckner-Tuderman
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

3.  A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes.

Authors:  M Ariza; V Alvarez; R Marín; S Aguado; C López-Larrea; J Alvarez; M J Menéndez; E Coto
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

4.  Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.

Authors:  W Lu; B Peissel; H Babakhanlou; A Pavlova; L Geng; X Fan; C Larson; G Brent; J Zhou
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

5.  Is there a third gene for autosomal dominant polycystic kidney disease?

Authors:  A D Paterson; Y Pei
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

6.  Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2.

Authors:  L Tsiokas; E Kim; T Arnould; V P Sukhatme; G Walz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

7.  Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA).

Authors:  R Morell; R A Spritz; L Ho; J Pierpont; W Guo; T B Friedman; J H Asher
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

8.  Somatic inactivation of Pkd2 results in polycystic kidney disease.

Authors:  G Wu; V D'Agati; Y Cai; G Markowitz; J H Park; D M Reynolds; Y Maeda; T C Le; H Hou; R Kucherlapati; W Edelmann; S Somlo
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

9.  PKD1 interacts with PKD2 through a probable coiled-coil domain.

Authors:  F Qian; F J Germino; Y Cai; X Zhang; S Somlo; G G Germino
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

10.  Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach.

Authors:  B Peral; V Gamble; C Strong; A C Ong; J Sloane-Stanley; K Zerres; C G Winearls; P C Harris
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

View more
  56 in total

Review 1.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

2.  Molecular diagnostics in autosomal dominant polycystic kidney disease: utility and limitations.

Authors:  Xiao Zhao; Andrew D Paterson; Alireza Zahirieh; Ning He; Kairong Wang; York Pei
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-12       Impact factor: 8.237

Review 3.  A mechanistic approach to inherited polycystic kidney disease.

Authors:  John J Bissler; Bradley P Dixon
Journal:  Pediatr Nephrol       Date:  2005-02-18       Impact factor: 3.714

Review 4.  Diagnosis and management of childhood polycystic kidney disease.

Authors:  William E Sweeney; Ellis D Avner
Journal:  Pediatr Nephrol       Date:  2010-10-29       Impact factor: 3.714

5.  Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.

Authors:  Yu Mi Woo; Jae-Bum Bae; Yeon-Hee Oh; Young-Gun Lee; Min Joo Lee; Eun Young Park; Jung-Kyoon Choi; Sunyoung Lee; Yubin Shin; Jaemyun Lyu; Hye-Yoon Jung; Yeon-Su Lee; Young-Hwan Hwang; Young-Joon Kim; Jong Hoon Park
Journal:  Hum Genet       Date:  2013-10-16       Impact factor: 4.132

6.  Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.

Authors:  Matthew B Lanktree; Amirreza Haghighi; Elsa Guiard; Ioan-Andrei Iliuta; Xuewen Song; Peter C Harris; Andrew D Paterson; York Pei
Journal:  J Am Soc Nephrol       Date:  2018-08-22       Impact factor: 10.121

7.  The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations.

Authors:  Emilie Cornec-Le Gall; Fouad T Chebib; Charles D Madsen; Sarah R Senum; Christina M Heyer; Brendan C Lanpher; Marc C Patterson; Robert C Albright; Alan S Yu; Vicente E Torres; Peter C Harris
Journal:  Am J Kidney Dis       Date:  2018-02-01       Impact factor: 8.860

8.  Family history of renal disease severity predicts the mutated gene in ADPKD.

Authors:  Moumita Barua; Onur Cil; Andrew D Paterson; Kairon Wang; Ning He; Elizabeth Dicks; Patrick Parfrey; York Pei
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

9.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

10.  Tuberous sclerosis and polycystic kidney disease in a 3-month-old infant.

Authors:  Martin W Laass; Miriam Spiegel; Anna Jauch; Gabriele Hahn; Edgar Rupprecht; Christian Vogelberg; Oliver Bartsch; Angela Huebner
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.